3 High-Yield Healthcare Stocks
One downside to a long-lasting bull market is that the market's dividend yield declines. That's a big problem for retirees who rely on their portfolio to meet their income needs.
Even in today's pricey market, there are a few high-yield stocks still worth buying. Want proof? We asked a team of healthcare investors to highlight a dividend stock stock that they think is still attractively priced. Read on to see why they picked GlaxoSmithKline (NYSE: GSK), HCP (NYSE: HCP), and Pfizer (NYSE: PFE).
Image source: Getty Images.
Source: Fool.com
Pfizer Inc. Aktie
22,03 €
0,83 %
Mehrere Buy-Einschätzungen bei Pfizer Inc., die die Sell-Zahlen überflügeln.
Ein prognostiziertes Kursziel von 29 € für Pfizer Inc. zeigt ein Potenzial von über 20% im Vergleich zum aktuellen Kurs von 22.03 €.
